Acrometastasis due to lung adenocarcinoma by Apollonatou, Vasiliki et al.
CASE REPORT
97www.journals.viamedica.pl
Address for correspondence: Andriana I. Papaioannou, 2nd Respiratory Medicine Department, Attikon University Hospital University of Athens, Athens Greece,  
e-mail: papaioannouandriana@gmail.com
DOI: 10.5603/ARM.2018.0013
Received: 26.02.2018
Copyright © 2018 PTChP
ISSN 2451–4934
Vasiliki Apollonatou, Stelios Loukides, Andriana I. Papaioannou, Spyros Papiris
2nd	Pulmonary	Medicine	Department,	Attikon	University	Hospital,	School	of	Medicine,	National	and	Kapidostrian	University	of	Athens,	
Athens,	Greece
Acrometastasis due to lung adenocarcinoma
The authors declare no financial disclosure
Abstract 
We	are	presenting	a	case	of	acrometastasis	in	a	male	patient	with	lung	adenocarcinoma.	Acrometastases	accumulate	for	0.1%	
of	all	metastatic	bone	 lesions	and	can	be	 the	first	manifestation	of	cancer	 in	approximately	10%	of	cases.	The	main	clinical	
manifestations	are	tenderness,	intermittent	pain,	functional	impairment,	erythema,	heat	and	swelling	of	the	affected	part.	Lung	
cancer	is	the	main	primary	malignancy	which	causes	acrometastases.	Although	the	lesions	can	be	recognized	in	x-rays	or	CT	
scans,	the	gold	standard	for	the	diagnosis	is	MRI	scan	in	which	the	full	extension	of	the	tumor	can	be	evaluated.The	diagnosis	
is	usually	confirmed	by	fine-needle	biopsy	of	the	affected	bone.	In	the	presence	of	acrometastases,	prognosis	is	very	poor	and	
palliative	treatment	is	usually	recommended.	This	case	shows	that	patients	at	risk	for	lung	cancer	should	be	screened	intensively	
when they develop persistent digital symptoms.
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Introduction
Despite the awareness of tobacco smoking 
and its consequences, lung cancer remains the 
most frequently diagnosed cancer globally [1]. 
The most common sites of metastasis are the 
nervous system, bones, liver, respiratory system 
and adrenal glands [2]. Acrometastases are very 
rare but may occur during or after the diagnosis 
of lung cancer. As new treatment options are 
available and life expectancy is prolonged, it is 
essential to recognize bone metastases as soon as 
possible. This could lead to better quality of life 
due to pain relief and to avoid skeletal related 
events such as pathological fractures [3]. We 
are presenting a case of acrometastasis which 
occurred as the first manifestation of lung cancer 
in a male patient presented in the emergency 
department. 
Case Presentation
A 72-year-old ex-smoker male patient with 
a smoking history of 50 pack-years presented in 
our department complaining about chest pain 
and a swallowing and painful right first toe. The 
patient reported that pain and swallow of the first 
toe occurred approximately one month before 
admission, while the onset of chest pain was 
approximately 15 days ago and was described as 
persistent and worsening with movements. Clini-
cal examination revealed a palpable and painless 
mass (2 × 2.5 cm) on the right hemithorax which 
was attached to the chest wall, and a swallowed 
and painful right fist toe (Fig. 1).Vital signs as 
well as the rest of the clinical examination were 
normal. Laboratory tests showed elevated white 
blood cell count (11.000 K/µL) and CRP (36 U/L), 
and uric acid levels within normal limits (4 mg/
Advances in Respiratory Medicine 2018, vol. 86, no. 2, pages 97–100 
98 www.journals.viamedica.pl
Figure 1. A	swollen,	painful	distal	phalanx	of	the	first	right	toe
Figure 2. Chest	X-Ray	revealing	linear	opacities	in	the	left	upper	field
Figure 3. A, B	—	CT	of	the	chest	showing	a	mass	of	3.5	×	3	cm	in	the	
anterior	segment	of	the	left	upper	lobe	which	was	causing	atelectasis	
of the surrounding lung parenchyma. C	—	subcutaneous	mass	2	×	
2.5	cm	on	the	right	hemithorax	(white	arrow)
dL). Chest X-Ray revealed linear opacities in the 
left upper field (Fig. 2). The patient was admitted 
to our department for further evaluation. 
A Chest CT scan was performed, andshowed 
a mass (3.5 × 3 cm) in the anterior segment of the 
left upper lobe and a subcutaneous mass of the 
right hemithorax (Fig. 3). Fiberoptic bronchosco-
py did not reveal any abnormalities.
Simultaneously, an X-ray of the right foot was 
performed and revealed a lytic lesion in the distal 
phalanx of the first metatarsal (Fig. 4). Computed 
tomography of lower limbs showed a complete 
destruction of the distal phalanx of the right first 
toe (Fig. 5). Bone scintigraphy was performed, 
showing increased uptake of the radioactive drug 
at the distal phalanx of the first toe, the spinal 
cord, several ribs, and the right humerus (Fig. 6).
A biopsy of the phalanx revealed acrometasta-
sis of the distal phalanx of the right first toe due to 
lung adenocarcinoma. Immunohistochemistry of 
this tissue sample revealed cancer cells which were 
positive for thyroid transcription factor-1 (TTF-1), 
CK7 and CK5/6, which confirmed the lung origin of 
the lesion while they were negative for ALK or EGFR 
gene mutations. The subcutaneous mass was excised 
as a whole (dimensions 4.8 × 3.2 × 1.5 cm) and 
sent for pathologic examination. The immunohis-
tochemistry of the tissue of the subcutaneous mass 
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Figure 4. A	lytic	lesion	in	the	distal	phalanx	of	the	first	metatarsal
Figure 5. CT of the right lower limp showing complete destruction of 
the	distal	phalanx	of	the	first	right	toe
Figure 6. A, B	—	bone	scintigraphy	revealing	increasing	uptake	of	the	
radioactive	drug	at	the	distal	phalanx	of	the	first	toe,	the	spinal	cord,	
some	ribs	as	well	as	the	right	humerus
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was positive for CK7, pCEA and MUC-1 and negative 
for CK20, CDX-2, TTF-1, CK34bE12, WT-1, RCC, 
and MUC5AC. This kind of immunohistochemistry, 
although not specific was also compatible with lung 
adenocarcinoma. According to the above the diagno-
sis is adenocarcinoma of the lung T2N2M1b, stage 
IVA. The patient was then referred to the oncology 
department for initiation of chemotherapy with 
carboplatin and gemcitabine. Microbiologic cultures 
of the biopsy material were negative.
Discussion 
Acrometastases, are metastases located distal 
to the elbow or knee [4]. They are rare presen-
tations of an end stage disease, accumulating 
for 0.1% of all metastatic bone lesions [5]. They 
are usually diagnosed in a patient with a history 
of already known malignancy, however, in ap-
proximately 10% of cases, they occur as the first 
manifestation of cancer [6]. 
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In the case of our patient the symptoms of 
acrometastasis were the first sign of lung cancer. 
The patient was complaining about pain and 
erythema of the right first toe for at least one 
month before admission and approximately two 
weeks before the onset of the chest pain. It was 
one of the main symptoms that brought him to 
the emergency department since he was mostly 
complaining about the pain on histoe rather than 
the chest pain, which was one of reasons that 
made us investigate it thoroughly. Even though 
bronchoscopy was normal,diagnosis was con-
firmed from the acrometastasis. 
In the presence of acrometastasis, the affected 
part may appear with tenderness, intermittent 
pain, functional impairment, erythema, heat and 
swelling. Differential diagnosis includes infec-
tions, cyst, gouty arthritis, ganglia, osteomyelitis, 
tuberculous dactylitis, pyogenic granuloma and 
primary skin tumors.The most common primary 
malignancy which causes acrometastases is lung 
cancer (32.9%), followed by renal cell (20%), 
breast (12.9%) and colon (10%) cancer [7]. 
In X-Rays the lesion is usually lytic, however, 
it depends on the primary tumour’s origin. CT 
is rarely useful and thus, the gold standard for 
the diagnosis is the MRI scan in which the full 
extension of the tumor can be evaluated [8].
Although the pathophysiologic mechanism 
leading to acrometastasis has not been fully un-
derstood, it is believed that tumor cells dissem-
ination to the digits occurs through circulation. 
This could explain the high prevalence of acrome-
tastases in the cases of lung cancer, because the 
tumour cells have direct access to the systemic 
circulation through left atrium and ventricle [9]. 
The diagnosis is confirmed by biopsy of the affect-
ed bone. Since acrometastases are rare, there is 
not enough evidence of the appropriate treatment. 
When they are diagnosed, the prognosis is very 
poor, (mean survival less than six months), and 
palliative treatment is usually recommended [10]. 
Amputation and chemotherapy have been used, 
but recent literature suggests that local radiation 
therapy could provide pain relieve and some 
function to the affected digit [11, 12]. 
Our case shows the importance of screening 
patients at risk for lung cancer when they develop 
persistent digital symptoms.
Conflict of interest
The authors declare no conflict of interest
References:
1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA 
Cancer J Clin. 2011; 61(2): 69–90, doi: 10.3322/caac.20107, 
indexed in Pubmed: 21296855.
2. Riihimäki M, Hemminki A, Sundquist J, et al. Patterns of meta-
stasis in colon and rectal cancer. Sci Rep. 2016; 6: 29765, doi: 
10.1038/srep29765, indexed in Pubmed: 27416752.
3. Brodowicz T, O’Byrne K, Manegold C. Bone matters in lung 
cancer. Ann Oncol. 2012; 23(9): 2215–2222, doi: 10.1093/an-
nonc/mds009, indexed in Pubmed: 22357445.
4. Mavrogenis AF, Mimidis G, Kokkalis ZT, et al. Acrometasta-
ses. Eur J Orthop Surg Traumatol. 2014; 24(3): 279–283, doi: 
10.1007/s00590-013-1311-1, indexed in Pubmed: 24013815.
5. Kerin R. Metastatic tumors of the hand. A review of the litera-
ture. J Bone Joint Surg Am. 1983; 65(9): 1331–1335, indexed 
in Pubmed: 6654944.
6. Abrahams TG. Occult malignancy presenting as metastatic 
disease to the hand and wrist. Skeletal Radiol. 1995; 24(2): 
135–137, indexed in Pubmed: 7747180.
7. Stomeo D, Tulli A, Ziranu A, et al. Acrometastasis: a literature 
review. Eur Rev Med Pharmacol Sci. 2015; 19(15): 2906–2915, 
indexed in Pubmed: 26241547.
8. Spiteri V, Bibra A, Ashwood N, et al. Managing acrometastases 
treatment strategy with a case illustration. Ann R Coll Surg 
Engl. 2008; 90(7): W8–11, doi: 10.1308/147870808X303137, 
indexed in Pubmed: 18831862.
9. Tolo ET, Cooney WP, Wenger DE. Renal cell carcinoma with 
metastases to the triquetrum: case report. J Hand Surg Am. 
2002; 27(5): 876–881, indexed in Pubmed: 12239679.
10. Campa T, Fagnoni E, Ripamonti C. Palliative surgery of acro-
metastases from lung cancer: a case report. Support Care Can-
cer. 2004; 12(3): 202–204, doi: 10.1007/s00520-003-0574-1, 
indexed in Pubmed: 14767749.
11. Flynn CJ, Danjoux C, Wong J, et al. Two cases of acrometastasis 
to the hands and review of the literature. Curr Oncol. 2008; 
15(5): 51–58, indexed in Pubmed: 19008991.
12. Sumodhee S, Huchot E, Peret G, et al. Radiotherapy for a 
phalanx bone metastasis of a lung adenocarcinoma. Case Rep 
Oncol. 2014; 7(3): 727–731, doi: 10.1159/000368345, indexed 
in Pubmed: 25493086.
